|
| 08:00-09:00 |
Oral Session 3 (Treatment)
Chairs: Woo HH (Stony Brook, NY), Chung KC (Seoul) |
|
|
[Grand Ballroom 1 & 2]
| Trial of Efficacy and Safety of Cilostzol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel: Trial of Cilostazol in Symptomatic Intracranial Stenosis-2 (TOSS-2) Baseline Characteristics and Current Status
Speaker: Kwon SU (Seoul) |
|
| Clinical and Angiographic Outcome of Self-Expandable Stenting in Symptomatic Intracranial Arterial Stenosis
Speaker: Leung T (Hong Kong) |
|
| Measurement of Clopidogrel-Induced Platelet Inhibition May Predict Early Complications Following Stent-Assisted Angioplasty for Symptomatic Intracranial Atherosclerotic Disease
Speaker: Lee SJ (Daejeon) |
|
| Intracranial Stenting in Patients with Intracranial Stenosis Associated with Adjacent Aneurysm
Speaker: In HS (Seoul) |
|
| Dynamic Cerebral Autoregulation in Patients with Recent Atherosclerotic Stroke during External Counterpulsation
Speaker: Xiong L (Hong Kong) |
|
|
|
|
| 08:00-09:00 |
Oral Session 4 (On-going Trials/Others)
Chairs: Chen C (Singapore), Heo JH (Seoul) |
|
|
[Chrysanthemum]
| Cilnidipine effect on High blood pressure and cERebral perfusion in Ischemic Stroke patients with Hypertension
Speaker: Hong KS (Seoul) |
|
| Aggressive Glucose Control in Acute Ischemic Stroke by Insulin Infusion (AGAIN) - pilot study
Speaker: Kim NY (Seoul) |
|
| Early Effect of Fluvastatin on Inflammatory Markers in Acute Ischemic Stroke (FIMA): Preliminary Ongoing Study
Speaker: Kim EG (Busan) |
|
| Circulating Pericyte Progenitor Cells as a Candidate Stem Cell Population in Acute Stroke
Speaker: Chu K (Seoul) |
|
| Effects of Uric Acid on Silent Brain Infarction in Healthy Elderly Adults
Speaker: Heo SH (Seoul) |
|
|
|
|
| 09:00-10:35 |
Invited Session 4: Medical Treatment vs. Intervention
Chairs: Chimowitz MI (Atlanta, GA), Suh DC (Seoul) |
|
|
| 09:00-09:20 |
Statin and other miscellaneous therapy |
Speaker: Chen C (Singapore) |
|
| 09:20-09:40 |
Stenting/Angioplasty, an effective treatment for intracranial stenosis |
Speaker: Jiang W-J (Beijing) |
|
| 09:40-10:00 |
Stenting vs. Medical therapy for symptomatic intracranial arterial stenosis |
Speaker: Chimowitz MI (Atlanta, GA) |
|
| 10:00-10:20 |
Self-expanding stenting for acute ischemic stroke |
Speaker: Woo HH (Stony Brook, NY) |
|
| 10:20-10:35 |
Panel discussion: Do we have enough evidence for stent/angioplasty? |
|
|
|
|
| 10:35-10:50 |
Coffee Break |
|
|
|
| 10:50-12:00 |
Interesting Case Discussion Chairs: Caplan LR, Yoon BW |
|
|
|
| 12:00-14:00 |
Luncheon Symposium (supported by Supported by Otsuka International Asia and Arab and Myung-in)
| 12:00-12:30 |
Prevention of stroke 2008 |
Chair: Poungvarin N
Speaker: Caplan LR (Boston, MA) |
|
| 12:30-13:00 |
Inflammation in acute stroke & intracranial atherosclerosis: potential role of
triflusal
|
Chair: Kim BS
Speaker: Arenillas JF (Barcelona) |
|
|
|
|
| 14:00-15:00 |
Oral Session 5 (Clinical aspects & Metabolic syndrome)
Chairs: Viereck J, (Boston, MA), Kim EG (Busan) |
|
|
[Grand Ballroom 1 & 2]
| Mirror Pattern of the Cerebral Artery Atherosclerosis in Patients with Acute Ischemic Stroke
Speaker: Kim YD (Seoul) |
|
| Intracranial Atherosclerosis in Anterior Cerebral Artery Territory Infarction: Its Significance and Stroke Mechanism
Speaker: Kim JS (Seoul) |
|
| Intracranial Atherosclerosis in Patients with CADASIL
Speaker: Choi JC (Jeju) |
|
| Endothelial Apoptosis Associated with Intracranial Atherosclerosis in Metabolic Syndrome
Speaker: Lee ST (Seoul) |
|
| Significant Associations of Metabolic Syndrome and Its Components with Silent Brain Infarction in Elderly People
Speaker: Kwon HM (Seoul) |
|
|
|
|
| 14:00-15:00 |
Oral Session 6 (Natural course & Prognosis)
Chairs: Arenillas JF (Barcelona), Rah JH (Incheon) |
|
|
[Chrysanthemum]
| Acute Symptomatic Intracranial Artery occlusion (ASIA) Study I: Natural History
Speaker: Lee WW (Seongnam) |
|
| Long-term Prognosis of Middle Cerebral Artery Stenosis under Medical Treatment
Speaker: Lee BC (Seoul) |
|
| Platelet Aggregation Might be an Important Factor for the Progression on Symptomatic Middle Cerebral Artery Stenosis?
Speaker: Cha JK (Seoul) |
|
| Intracranial Angioplasty for Symptomatic Middle Cerebral Artery Stenosis: Long-Term Follow-Up
Speaker: Kim JT (Seoul) |
|
|
|
|
| 15:00-15:20 |
Coffee Break |
|
|
|
| 15:20 - 16:55 |
Invited Session 5: Other Therapies and Clinical Outcome
Chairs: Leys D (Lille), Oh CW(Seoul) |
|
|
| 15:20-15:40 |
Intracranial atherosclerosis: natural course and prognosis |
Speaker: Arenillas JF (Barcelona) |
|
| 15:40-16:00 |
Antithrombotic therapy in symptomatic intracranial stenosis |
Speaker: Lee YS (Seoul) |
|
| 16:00-16:20 |
Surgical treatment of moyamoya disease |
Speaker: Steinberg GK (Stanford, CA) |
|
| 16:20-16:40 |
Rehabilitation following ischemic stroke caused by intracranial atherosclerosis |
Speaker: Paik NJ (Seongnam) |
|
| 16:40-17:00 |
Panel discussion: Therapies that can affect the outcome of ICAS |
|
|
|
|
| 17:00-17:10 |
Closing Remarks |
|
|
| 17:05-17:10 |
Introduction of the 4th conference on intracranial atherosclerosis |
Speaker: Jiang W-J (Beijing) |
|
|
